Skip to main content
Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
48.84
+1.84 (3.90%)
At close: Dec 5, 2025

Novo Nordisk Revenue

Novo Nordisk had revenue of 74.98B DKK in the quarter ending September 30, 2025, with 5.14% growth. This brings the company's revenue in the last twelve months to 315.60B, up 16.64% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

Revenue (ttm)
315.60B DKK
Revenue Growth
+16.64%
P/S Ratio
4.32
Revenue / Employee
4.08M DKK
Employees
77,349
Market Cap
214.27B USD

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veradigm 588.02M
Elite Pharmaceuticals 122.89M
Glass House Brands 196.17M
American Oncology Network 1.76B
Northwest Biotherapeutics 937.00K
Silence Therapeutics 25.83M
Global Cord Blood 196.10M
Zomedica 29.45M
Revenue Rankings

Novo Nordisk News

More News